Publication:
Protective Effects of Probiotic Consumption in Cardiovascular Disease in Systemic Lupus Erythematosus.

Loading...
Thumbnail Image

Date

2019-10-28

Authors

de la Visitacion, Nestor
Robles-Vera, Iñaki
Toral, Marta
Duarte, Juan

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

MDPI AG
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

The prevalence of renal and cardiovascular disease (CVD) in patients with systemic lupus erythematosus (SLE) is higher than in general populations. Recently, a causal role of gut microbiota on the development of immune responses in SLE has been described. Probiotic consumption changes the composition of gut microbiota, preventing SLE progression. The aim of this review is to explore the role of the gut microbiota in the development of renal and cardiovascular disease in SLE and how probiotics could be a therapeutic option. Despite strong evidence on the beneficial effects of probiotics in the development of autoimmunity and nephritis in SLE, only a few studies described the protective effects of Lactobacillus in important risk factors for CVD, such as endothelial dysfunction and hypertension in mice. The preventive effects of probiotics in renal and CVD in humans have not been established yet.

Description

MeSH Terms

Animals
Cardiovascular Diseases
Gastrointestinal Microbiome
Kidney Diseases
Lactobacillus
Lupus Erythematosus, Systemic
Mice
Probiotics
Protective Agents
Risk Factors

DeCS Terms

Animales
Enfermedades cardiovasculares
Enfermedades renales
Factores de riesgo
Lactobacillus
Lupus eritematoso sistémico
Microbioma gastrointestinal
Probióticos
Ratones
Sustancias protectoras

CIE Terms

Keywords

endothelial dysfunction, gut microbiota, hypertension, immune response, nephritis

Citation

de la Visitación N, Robles-Vera I, Toral M, Duarte J. Protective Effects of Probiotic Consumption in Cardiovascular Disease in Systemic Lupus Erythematosus. Nutrients. 2019 Nov 5;11(11):2676.